New BioNavigate Suite of Online Courses You Do Not Want to Miss Out On!  

Introducing BioNavigate, a focused suite of professional development courses concentrating on biologic and biosimilar medications. RxA has launched a suite of online BioNavigate courses focused on adalimumab and biosimilars of adalimumab. There are 6 newly available online courses on GoPharmacist Learn: 

  1. Adalimumab and Biosimilars: Pharmacology 
  1. Adalimumab and Biosimilars: Preparing for and Communicating About Therapy 
  1. Adalimumab and Biosimilars: Real World Considerations for Monitoring Therapy 
  1. Adalimumab and Biosimilars: Device Training and Administration 
  1. Adalimumab and Biosimilars: Patient Support Programs 
  1. Adalimumab and Biosimilars: Navigating the Switch 

This suite of courses provides 2.75 CCCEP accredited CEUs, as well as 2 hours of non-accredited learning. Once completed, you will have a thorough understanding of adalimumab and its biosimilars, as well as other facets of the biosimilar realm. This will prepare you for the upcoming switch deadline of May 1, 2022, for patients with government-sponsored drug plans from the adalimumab biologic to an adalimumab biosimilar. You can find all the courses on GoPharmacist Learn.